scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Rajagopal Ramesh | Q47105152 |
P2093 | author name string | Anish Babu | |
Anupama Munshi | |||
Ranganayaki Muralidharan | |||
Narsireddy Amreddy | |||
P2860 | cites work | Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties | Q21562142 |
Global cancer statistics | Q22241238 | ||
Polylysine-modified polyethylenimine inducing tumor apoptosis as an efficient gene carrier. | Q50857814 | ||
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. | Q51466557 | ||
Biomimetic strategies for targeted nanoparticle delivery. | Q55209384 | ||
Gene therapy for lung cancer | Q58409685 | ||
Toxicity of Pluronic F-68 | Q69501643 | ||
Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlates | Q71079474 | ||
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes | Q71604126 | ||
Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA | Q85846218 | ||
Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method | Q40575336 | ||
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery | Q40713744 | ||
Polyethylenimine-mediated gene delivery: a mechanistic study | Q40810570 | ||
Cellular delivery of shRNA using aptamer-conjugated PLL-alkyl-PEI nanoparticles | Q41267425 | ||
PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. | Q41781215 | ||
Expression of CD44 in human lung tumors. | Q42475640 | ||
The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH. | Q42541130 | ||
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine | Q43804737 | ||
pH-sensitive unimolecular polymeric micelles: synthesis of a novel drug carrier | Q44513944 | ||
Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis | Q44623128 | ||
Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy | Q45855846 | ||
The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles | Q45884412 | ||
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway | Q45887270 | ||
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. | Q45888706 | ||
Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies | Q46763514 | ||
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery | Q47620102 | ||
The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA. | Q48971998 | ||
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles | Q48972059 | ||
Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer | Q50326340 | ||
Targeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticles. | Q38983637 | ||
Postoperative radiotherapy for lung cancer: Is it worth the controversy? | Q38992790 | ||
Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery | Q39247726 | ||
Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth | Q39290507 | ||
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles | Q39496907 | ||
Targeted drug and gene delivery systems for lung cancer therapy | Q39773632 | ||
Expression profiling of integrins in lung cancer cells | Q39813409 | ||
Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery | Q39831016 | ||
Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo | Q39838698 | ||
Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells | Q39842082 | ||
Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation | Q39854733 | ||
Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer | Q39906541 | ||
Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway | Q39919589 | ||
Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. | Q40049006 | ||
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. | Q40095319 | ||
Studies on polyamidoamine dendrimers as efficient gene delivery vector | Q40108825 | ||
Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents | Q40199051 | ||
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. | Q40204412 | ||
Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine | Q40510338 | ||
PLGA-based nanoparticles: an overview of biomedical applications. | Q37986980 | ||
Polyethylenimine as a promising vector for targeted siRNA delivery | Q37995332 | ||
RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis | Q38042484 | ||
Biomedical applications of carboxymethyl chitosans | Q38050253 | ||
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier | Q38086322 | ||
Nanoparticle-mediated pulmonary drug delivery: a review | Q38203377 | ||
Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy | Q38209539 | ||
Non-small-cell lung cancers: a heterogeneous set of diseases | Q38233321 | ||
RNA interference: mechanisms, technical challenges, and therapeutic opportunities | Q38260606 | ||
The folate receptor as a rational therapeutic target for personalized cancer treatment | Q38280014 | ||
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells | Q38302239 | ||
Principles in the design of ligand-targeted cancer therapeutics and imaging agents. | Q38362491 | ||
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future | Q38390200 | ||
Aerosol delivery of folate-decorated hyperbranched polyspermine complexes to suppress lung tumorigenesis via Akt signaling pathway | Q38738427 | ||
Gene delivery to neuroblastoma cells by poly (l-lysine)-grafted low molecular weight polyethylenimine copolymers. | Q38775145 | ||
siRNA-Loaded Polyion Complex Micelle Decorated with Charge-Conversional Polymer Tuned to Undergo Stepwise Response to Intra-Tumoral and Intra-Endosomal pHs for Exerting Enhanced RNAi Efficacy | Q38815969 | ||
Nanoparticle-based targeted gene therapy for lung cancer | Q38854207 | ||
Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. | Q38856885 | ||
Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight | Q38873132 | ||
EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82. | Q38882303 | ||
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape | Q38922208 | ||
CD44 in cancer progression: adhesion, migration and growth regulation | Q35875561 | ||
Expression of EGFR Is Closely Related to Reduced 3-Year Survival Rate in Chinese Female NSCLC | Q36010179 | ||
Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance | Q36050687 | ||
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells | Q36161060 | ||
Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy | Q36244267 | ||
Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery | Q36303165 | ||
Dendrimers in biomedical applications--reflections on the field | Q36321345 | ||
Dendrimers for pharmaceutical and biomedical applications | Q36367723 | ||
The transferrin receptor and the targeted delivery of therapeutic agents against cancer. | Q36406637 | ||
Targeted polymeric nanoparticles for cancer gene therapy | Q36416427 | ||
Soluble and cell-associated transferrin receptor in lung cancer | Q36421973 | ||
Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies | Q36437187 | ||
Natural polymers for gene delivery and tissue engineering | Q36500669 | ||
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery | Q36525361 | ||
Biological and clinical implications of EGFR mutations in lung cancer. | Q36540571 | ||
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors | Q36795709 | ||
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed | Q36821156 | ||
Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery | Q36858384 | ||
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation | Q36934007 | ||
Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles. | Q36951261 | ||
Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models | Q37013417 | ||
Biodegradable polymers as non-viral carriers for plasmid DNA delivery | Q37059381 | ||
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer. | Q37065575 | ||
Folate-conjugated polyspermine for lung cancer-targeted gene therapy | Q37110638 | ||
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. | Q37126978 | ||
Polymeric nanoparticles for siRNA delivery and gene silencing | Q37139407 | ||
Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. | Q37383038 | ||
Chitosan-based formulations for delivery of DNA and siRNA. | Q37606697 | ||
Integrin signaling and lung cancer. | Q37688804 | ||
The Tumor Microenvironment in Non–Small-Cell Lung Cancer | Q37777872 | ||
Chitosan as a carrier for targeted delivery of small interfering RNA | Q37781876 | ||
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery | Q37835914 | ||
Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery. | Q37881431 | ||
The ligand nanoparticle conjugation approach for targeted cancer therapy | Q37926603 | ||
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer | Q27021261 | ||
Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition | Q27679502 | ||
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 | ||
Targeting HIF-1 for cancer therapy | Q27860504 | ||
Polymeric nanoparticles for targeted treatment in oncology: current insights | Q28087243 | ||
The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells | Q28258883 | ||
Molecular mechanisms of RNA interference | Q28290306 | ||
The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? | Q28295141 | ||
Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells | Q28548503 | ||
RNA therapeutics: RNAi and antisense mechanisms and clinical applications | Q28829240 | ||
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration | Q28829561 | ||
Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
Microenvironmental regulation of tumor progression and metastasis | Q29615504 | ||
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine | Q29616154 | ||
The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells | Q33360157 | ||
Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review | Q34028901 | ||
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells | Q34075391 | ||
Gene therapy in lung cancer | Q34107787 | ||
Poly(ethylene oxide) grafted with short polyethylenimine gives DNA polyplexes with superior colloidal stability, low cytotoxicity, and potent in vitro gene transfection under serum conditions. | Q34160329 | ||
Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1. | Q34278743 | ||
Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model | Q34293616 | ||
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis | Q34367669 | ||
EGFR and cancer prognosis | Q34399312 | ||
Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis | Q34496985 | ||
Block copolymer micelles for delivery of gene and related compounds | Q34565334 | ||
Integrin alpha v beta 3-targeted imaging of lung cancer | Q34768362 | ||
Gene therapy progress and prospects cancer: oncolytic viruses. | Q34770611 | ||
Chitosan and its derivatives--a promising non-viral vector for gene transfection | Q34831284 | ||
Review of the oral toxicity of polyvinyl alcohol (PVA). | Q35035163 | ||
Gene therapy for cancer treatment: past, present and future | Q35040146 | ||
Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. | Q35100982 | ||
Implantable applications of chitin and chitosan | Q35109251 | ||
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells | Q35537936 | ||
Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo | Q35562133 | ||
Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors | Q35624123 | ||
Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations | Q35831012 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | gene therapy | Q213901 |
manufactured product | Q3406743 | ||
lung neoplasm | Q15124212 | ||
biomedical investigative technique | Q66648976 | ||
macromolecular substance | Q75174158 | ||
nanoparticle | Q61231 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 35 | |
P577 | publication date | 2017-03-13 | |
2017-04-01 | |||
P1433 | published in | Topics in Current Chemistry | Q2443282 |
P1476 | title | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment | |
P478 | volume | 375 |
Search more.